← All stocks

Atrium Therapeutics, Inc.

RNA No buying or selling

CIK 0002093101 #3847 in the set updated 22 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

6 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Gallagher Kathleen P.

See Remarks

—

131,361

—

+355.2%

Hughes Steven George

Chief Medical Officer

—

73,097

—

+69.6%

Younis Husam

Chief Scientific Officer

—

52,657

—

+132.4%

Hoyos Rocio Martin

Chief Strategy Officer

—

46,660

—

+180.1%

Winslow Brendan R.

Chief Financial Officer

—

43,601

—

+220.6%

Kenney Stephanie

See Remarks

—

35,460

—

+549.5%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 2 Mar 2026